SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-105870
Filing Date
2024-04-23
Accepted
2024-04-23 07:00:57
Documents
12
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d448465ddef14a.htm DEF 14A 390008
2 GRAPHIC g448465dsp2.jpg GRAPHIC 1221
3 GRAPHIC g448465dsp2a.jpg GRAPHIC 9694
4 GRAPHIC g448465dsp2b.jpg GRAPHIC 83192
5 GRAPHIC g448465dsp2c.jpg GRAPHIC 18201
6 GRAPHIC g448465dsp2d.jpg GRAPHIC 2929
7 GRAPHIC g448465dsp2e.jpg GRAPHIC 2470
8 GRAPHIC g448465dsp2f.jpg GRAPHIC 1668
9 GRAPHIC g448465dsp2g.jpg GRAPHIC 2929
10 GRAPHIC g448465dsp3a.jpg GRAPHIC 9694
11 GRAPHIC g448465dsp3c.jpg GRAPHIC 1429
12 GRAPHIC g448465g01a02.jpg GRAPHIC 35074
  Complete submission text file 0001193125-24-105870.txt   624801
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39103 | Film No.: 24862666
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)